39.09
Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten
Short interest data insights for Xenon Pharmaceuticals Inc.July 2025 Closing Moves & Free Community Supported Trade Ideas - newser.com
XENE: RBC Capital Raises Price Target to $58, Maintains Outperfo - GuruFocus
What drives Xenon Pharmaceuticals Inc stock priceConsumer Goods Stocks & Free Stay Informed With Forecasts - earlytimes.in
Wells Fargo Adjusts Xenon Pharmaceuticals (XENE) Price Target Am - GuruFocus
Cantor Fitzgerald reiterates Overweight rating on Xenon Pharmaceuticals stock By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Overweight rating on Xenon Pharmaceuticals stock - Investing.com
Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus - TradingView
Wedbush Lifts Price Target on Xenon Pharmaceuticals to $44 From $43, Keeps Outperform Rating - MarketScreener
RBC Raises Price Target on Xenon Pharmaceuticals to $58 From $55, Keeps Outperform, Speculative Risk - MarketScreener
Why Xenon Pharmaceuticals Inc. stock could outperform in 2025July 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com
How strong is Xenon Pharmaceuticals Inc. stock revenue growthProfit Target & Community Consensus Trade Alerts - newser.com
What MACD and RSI say about Xenon Pharmaceuticals Inc.Weekly Trade Recap & Weekly Return Optimization Alerts - newser.com
XENE: Needham Reiterates Buy Rating with Price Target of $55.00 - GuruFocus
Can Xenon Pharmaceuticals Inc. stock deliver sustainable ROEWeekly Volume Report & Safe Entry Point Alerts - newser.com
Chart overlay techniques for tracking Xenon Pharmaceuticals Inc.July 2025 Recap & Capital Efficiency Focused Ideas - newser.com
Intraday pattern recognizer results for Xenon Pharmaceuticals Inc.July 2025 EndofMonth & Community Consensus Stock Picks - newser.com
Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlight - GuruFocus
Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlights: Strong Financial Position ... - Yahoo Finance
Xenon Pharmaceuticals Reports Q3 2025 Financial Results - TipRanks
Xenon Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat
Tools to monitor Xenon Pharmaceuticals Inc. recovery probabilityDay Trade & Weekly Top Stock Performers List - newser.com
Why Xenon Pharmaceuticals Inc. stock is trending among retail tradersQuarterly Trade Review & Weekly Market Pulse Updates - newser.com
Earnings call transcript: Xenon Pharmaceuticals Q3 2025 sees steady cash reserves - Investing.com Philippines
Earnings Flash (XENE) Xenon Pharmaceuticals Posts Q3 EPS $-1.15, vs. FactSet Est of $-1.15 - MarketScreener
XENE Financial Position Update: Cash Holdings Decline - GuruFocus
Xenon Pharmaceuticals: Q3 Earnings Snapshot - San Francisco Chronicle
Xenon Reports Q3 2025 Financial Results and Progress - TipRanks
Xenon Pharmaceuticals Inc. SEC 10-Q Report - TradingView
Xenon Pharmaceuticals Keeps R&D Rolling While Analysts Stay Bullish - Finimize
Xenon Reports Third Quarter 2025 Financial Results & Business Update - The Manila Times
Xenon Pharmaceuticals Q3 net loss beats expectations - MarketScreener
When is the best time to exit Xenon Pharmaceuticals Inc.Portfolio Update Summary & Target Return Focused Stock Picks - newser.com
Will Xenon Pharmaceuticals Inc. price bounce be sustainableInsider Buying & Expert Verified Stock Movement Alerts - newser.com
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees - MSN
Using Ichimoku Cloud for Xenon Pharmaceuticals Inc. technicalsIndex Update & Fast Momentum Entry Tips - newser.com
Technical signs of recovery in Xenon Pharmaceuticals Inc.Recession Risk & Weekly High Potential Alerts - newser.com
What valuation multiples suggest for Xenon Pharmaceuticals Inc. stock - newser.com
State of New Jersey Common Pension Fund D Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals Inc. $XENE Position Trimmed by Jennison Associates LLC - MarketBeat
Will Xenon Pharmaceuticals Inc. stock continue dividend increasesJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):